5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis (Q37780679)

23 August 2017

0 references

5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis (English)

1 reference

23 August 2017

0 references

0 references

1 reference

1

Alexander C Ford

0 references

Paul Moayyedi

object named as

Paul Moayyedi

series ordinal

4

0 references

Nicholas Talley

series ordinal

3

object named as

Nicholas J Talley

1 reference

23 August 2017

Khurram J Khan

2

1 reference

23 August 2017

language of work or name

English

0 references

publication date

17 August 2010

1 reference

The American Journal of Gastroenterology

23 August 2017

published in

1 reference

23 August 2017

volume

106

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

413-420

1 reference

Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

Incidence of Crohn's Disease in Four Counties in Southeastern Norway, 1990–93 A Prospective Population-Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

A controlled double blind study of azathioprine in the management of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

Errors in the conduct of systematic reviews of pharmacological interventions for irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

Sulphasalazine in asymptomatic Crohn's disease. A multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

The long-term prophylactic effect of salazosulphapyridine (Salazopyrin) in primarily resected patients with Crohn's disease. A controlled double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

Management of Crohn's disease in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

Guidelines for the management of inflammatory bowel disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

European evidence based consensus on the diagnosis and management of Crohn's disease: special situations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

Infliximab prevents Crohn's disease recurrence after ileal resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.317

21 January 2018

Identifiers

DOI

10.1038/AJG.2010.317

1 reference

Dimensions Publication ID

23 August 2017

1016351737

0 references

1 reference